// App-Quantinova.ai

730P : A PHASE II STUDY ON COMBINATION OF AXITINIB AND TRANSARTERIAL CHEMOEMBOLIZATION (TACE) FOR TREATMENT OF INOPERABLE HEPATOCELLULAR CARCINOMA (HCC)

Researchers

Presenter

  • S.L. Chan

Principal Investigators

  • W. Yeo

  • F. Mo

  • L. Li

  • K. Lee

  • P. Hui

  • B. Ma

  • T.S.K. Mok

  • A.T.C. Chan

  • P.B.S. Lai

  • S.C.H. Yu

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Inlyta

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved